Cross-linked carboxymethylcellulose sodium is a pharmaceutical excipient used as a disintegrant for tablets, capsules and granules in oral preparations.
Used in food supplements for dietary supplements. In the pharmaceutical industry, it is used as a disintegrating agent in tablets, capsules and granules, and has good disintegration effect, high speed and uniform dispersion, and is known as "super disintegrant". Generally used in tablets in the amount of 0.5-5%

The global Cross–Linked Sodium Carboxymethyl Cellulos market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cross–Linked Sodium Carboxymethyl Cellulos volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cross–Linked Sodium Carboxymethyl Cellulos market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cross–Linked Sodium Carboxymethyl Cellulos in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cross–Linked Sodium Carboxymethyl Cellulos manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
DFE Pharma
JRS PHARMA
DuPont Nutrition & Health
MINGTAI CHEMICAL
Asahi Kasei
NB Entrepreneurs
Blanver
ALPHA
Anhui Sunhere Pharmaceutical Excipients
Shandong Yulong Cellulose Technology

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Cotton Based
Wood Pulp based

Segment by Application
Pharmaceutical
Food